Your browser doesn't support javascript.
loading
Mycobacterium tuberculosis-Specific T Cell Functional, Memory, and Activation Profiles in QuantiFERON-Reverters Are Consistent With Controlled Infection.
Mpande, Cheleka A M; Steigler, Pia; Lloyd, Tessa; Rozot, Virginie; Mosito, Boitumelo; Schreuder, Constance; Reid, Timothy D; Bilek, Nicole; Ruhwald, Morten; Andrews, Jason R; Hatherill, Mark; Little, Francesca; Scriba, Thomas J; Nemes, Elisa.
Affiliation
  • Mpande CAM; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Steigler P; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Lloyd T; Wellcome Centre for Infectious Diseases Research (CIDRI) in Africa, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Rozot V; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Mosito B; Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa.
  • Schreuder C; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Reid TD; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Bilek N; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Ruhwald M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Andrews JR; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Hatherill M; Statens Serum Institut, Copenhagen, Denmark.
  • Little F; Foundation of Innovative New Diagnostics, Geneva, Switzerland.
  • Scriba TJ; Department of Medicine, Stanford University, Stanford, CA, United States.
  • Nemes E; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Front Immunol ; 12: 712480, 2021.
Article in En | MEDLINE | ID: mdl-34526988
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / T-Lymphocyte Subsets / Interferon-gamma Release Tests / Immunologic Memory / Mycobacterium tuberculosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / T-Lymphocyte Subsets / Interferon-gamma Release Tests / Immunologic Memory / Mycobacterium tuberculosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: Country of publication: